The percentage of cancer neoantigens that are spontaneously recognized by T cells is generally very low. This protocol describes how CD8+ T cells from healthy donors can be used for enhanced targeting of these neoantigens.
- Muhammad Ali
- Zsofia Foldvari
- Johanna Olweus